Focus on Growth. Capital Markets Day May 23rd Siobhán Talbot Group MD. Glanbia Group. Glanbia Financials. Glanbia Nutritionals

Transcription

1 Glanbia Group Glanbia Nutritionals Glanbia Financials Focus on Growth Capital Markets Day May 23rd lanbia Performance Nutrition Siobhán Talbot Group MD

2 Important Notice 2

3 Speaker Topic Timing Siobhan Talbot Group Managing Director, Glanbia Strategy and ambition 8:00am to 8.45am Brian Phelan CEO, Glanbia Nutritionals GN overview and growth drivers 8.45am to 9.30am Break 10 minutes Hugh McGuire CEO, Glanbia Performance Nutrition GPN overview and growth drivers 9.40am to 10.25am Mark Garvey CFO, Glanbia plc Financial track record and targets 10.25am to 11.10am Q& A with all speakers 11.10am to 11.50am Innovation GPN and GN innovation 12.00pm to 1.00pm Lunch and product displays Brand and product sampling 1.00pm to 2.00pm 3

4 At a glance Market cap 4.3bn Employees 6,600 Countries Total Group revenues 3.6bn 2017 Total Group EBITA 351m Products sold or distributed in over 130 countries 4

5 2022 AMBITION Total Group Constant revenue Currency 5 bn* Average 5 year adjusted Constant EPS growth Currency 5 % to 10 %* *Constant Currency Future journey- a mix of organic and M&A enabled growth 5

6 Our purpose Delivering better nutrition for every step of life s journey 6

7 Leading positions in nutrition #1 Global Performance nutrition brand portfolio #1 Global whey protein, nutritional solutions #1 Producer of American style cheddar cheese #1 in Irish Dairy and EU Mozzarella in strategic partnerships 7

8 Trends driving our business Aligning our business to consumer and customer needs Health and wellness On-the-go food and beverages Digitally connected Clean labelling $1tr Global health and wellness sales hit a record high in % of American consumers reach for a snack at least once-a-day. $4.5 tr online retail sales expected to have a CAGR of 18% from % of US households have purchased a clean label product. Source: Euromointor/ NBJ/ Stastica /Nielsen 8

9 SHARE OF REVENUE WHOLLY OWNED Our business in 2017 Total Group Revenues 3.6bn* Activity EBITA Margin GPN 1.1bn Performance & lifestyle consumer branded portfolio Mid teens Nutritional Solutions 0.5bn Value added formulations GN US Cheese 0.7bn Joint Ventures 1.3bn Dairy Mid single digits 9 *Pro forma including the full year impact of acquisitions in Joint Ventures.

10 Strong record of delivery 10 Year wholly-owned owned margin revenues Earnings per share 14% 12% 10% 8% 6% 4% 2% 0% bps Wholly-owned margin Wholly-owned margin c 90.00c 80.00c 70.00c 60.00c 50.00c 40.00c 30.00c 20.00c 10.00c 0.00c % CAGR Adjusted Earnings per share Adjusted Earnings per share 10

11 Focused strategic execution ASEPTIC SOLUTIONS USA Disciplined M&A Organic growth projects and strategic alliances Premix facility Germany Specialty grain ingredients South Dakota New GPN production plant Illinois High end whey expansion Idaho GPN innovation centre Illinois Cheese & whey expansion New Mexico Significant financial capacity for future investment 11

12 Our growth strategy Our Purpose To deliver better nutrition for every step of life s journey Our Vision To be one of world s top performing nutrition companies trusted to enrich lives every day Global Macro Trends Health and wellness On-the-go food and beverages Digitally connected Clean labelling Strategic Pillars Protect and grow the core Concentrate our focus in growing markets where we have market leading capability and right to win Invest in capability to capture market opportunities Selectively build and scale beyond the core Invest to drive organic growth across key adjacencies to current platforms Build scale internationally Deliver complementary M&A Embed enablers across the business Focus on; Leveraging the operating model Driving customer and consumer engagement Developing and retaining top talent Rigorous cost management 12

13 Our growth strategy Embed enablers Protect and grow the core GPN Drive Global & Regional flagship brands Focus on international markets NS Build on protein expertise, premix solutions and bioactives Drive innovation & international markets Selectively build beyond the core GPN Innovate for the Active consumer Direct to Consumer and digital capabilities NS Expand into adjacencies leveraging knowledge of flavors and plant nutrition Scalable model across GPN, GN and Dairy Invest in insights, technology and innovation Develop powerful digital capabilities Rigorous cost management to fuel and fund growth Attract, develop, retain the best talent Dairy Sustain #1 US cheese position Capture growth via strategic partnerships Future journey will be a mix of organic and M&A enabled growth 13

14 Talent Focus A pipeline of highly engaged staff with the capabilities and performance to execute Group strategy Talent Source Grow Retain Organisational Effectiveness New Capabilities Strategic Alignment Competitiveness Agility Leadership Select Develop Succession Constant Currency Culture & Engagement Values Leader led Inclusive 14

15 SHARE OF REVENUE WHOLLY OWNED Our ambition by 2022 to be a 5bn+ Group Revenue ambition by 2022 Average 5 year EBITA Margin 2018 to 2022 GPN 1.6bn 13% - 15% Nutritional Solutions US Cheese Joint Ventures 0.8bn 0.7bn 1.9bn 14% - 16% Mid single digits Average 5 year adjusted EPS growth, constant Constant currency, 2018 Currency to % to 10% Future journey will be a mix of organic and M&A enabled growth 15